Ignyte Acquisition registered to offer 5 million units at $10 each to raise $50 million in an IPO.
The new SPAC is focused on the life sciences, biotechnology and healthcare sectors.
Ignyte is led by Chairman and Co-CEO David Rosenberg, the Co-CEO and Co-President of Ladenburg Thalmann.
Ignyte plans to list on the Nasdaq under IGNYU. Read more.
